89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding 89bio, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 106 | 1 | 147 | +42 |
| Shares | 46.3M | 67.4K | 71.0M | +24.7M (+53.5%) |
| Value | $589.5M | $858.0K | $1.08B | +$492.4M (+83.7%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (61)
Institutions that held 89bio, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (19)
Institutions that held 89bio, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| OrbiMed Advisors LLC | 3,658,869 | $46.6M |
| Commodore Capital LP | 758,244 | $9.65M |
| Walleye Capital LLC | 479,756 | $6.11M |
| Ikarian Capital, LLC | 454,000 | $5.78M |
| DAFNA Capital Management LLC | 324,173 | $4.13M |
| Sphera Funds Management Ltd. | 180,600 | $2.30M |
| Alliancebernstein L.P. | 130,877 | $1.67M |
| EAM Global Investors LLC | 125,394 | $1.60M |
| Trexquant Investment LP | 62,034 | $789.7K |
| HRT Financial LP | 56,194 | $715.0K |
| Acadian Asset Management LLC | 51,861 | $660.0K |
| Pura Vida Investments, LLC | 50,000 | $636.5K |
| Bank of Montreal | 34,233 | $436.1K |
| Dynamic Technology Lab Private Ltd | 22,362 | $285.0K |
| Balyasny Asset Management LLC | 22,159 | $282.1K |
| Bayesian Capital Management, LP | 18,009 | $229.3K |
| Tudor Investment Corp Et Al | 11,142 | $142.0K |
| Fox Run Management, L.L.C. | 10,053 | $128.0K |
| Rockefeller Capital Management L.P. | 1,000 | $12.0K |
Not filed for Q1 2023 yet (1)
Institutions that held 89bio, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Alpha Paradigm Partners, LLC | 67,433 | $858.0K |